Enliven Therapeutics, Inc.
ELVN
$36.32
$0.210.58%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -2.21% | -3.13% | -2.64% | 69.40% | -7.62% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -12.41% | 139.49% | -0.02% | 7.47% | 2.81% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -2.47% | -1.62% | -2.61% | 68.40% | -7.48% |
|
|
|||||
| Total Current Assets | -2.47% | -1.62% | -2.61% | 68.40% | -7.48% |
| Net Property, Plant & Equipment | -25.66% | -52.29% | -14.81% | -2.75% | 130.35% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 60.94% | -88.07% | 1.09% | 0.58% | 0.31% |
| Total Assets | -2.38% | -3.00% | -2.58% | 66.54% | -7.12% |
|
|
|||||
| Total Accounts Payable | -24.04% | 51.08% | -39.22% | 50.51% | 16.39% |
| Total Accrued Expenses | -30.90% | 7.15% | 2.63% | 4.39% | -17.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -24.31% | 3.10% | 2.93% | 3.01% | -- |
| Total Finance Division Other Current Liabilities | -69.52% | 308.14% | 36.51% | -56.85% | -28.43% |
| Total Other Current Liabilities | -69.52% | 308.14% | 36.51% | -56.85% | -28.43% |
| Total Current Liabilities | -30.67% | 13.09% | -3.69% | 8.87% | -12.21% |
|
|
|||||
| Total Current Liabilities | -30.67% | 13.09% | -3.69% | 8.87% | -12.21% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -49.51% | -32.45% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -30.67% | 12.30% | -4.29% | 7.99% | -10.31% |
|
|
|||||
| Common Stock & APIC | 2.25% | 1.64% | 0.94% | 40.27% | 1.28% |
| Retained Earnings | -6.81% | -9.34% | -6.78% | -9.31% | -11.72% |
| Treasury Stock & Other | -214.37% | 51.13% | 224.86% | -1,006.25% | -129.09% |
| Total Common Equity | -1.36% | -3.47% | -2.53% | 69.43% | -6.95% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.36% | -3.47% | -2.53% | 69.43% | -6.95% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.36% | -3.47% | -2.53% | 69.43% | -6.95% |
|
|
|||||